A Novel Iron-Based Supplement for Athletes Aged 18-25: Phase II
- Conditions
- Iron Deficiencies
- Interventions
- Other: FeSC
- Registration Number
- NCT06269913
- Lead Sponsor
- University of Calgary
- Brief Summary
Female endurance athletes are susceptible to iron deficiency and this can impact their exercise performance. This study aims to assess the efficacy of a novel iron supplement in improving iron status, gut microbiome, and exercise performance in endurance-trained females.
- Detailed Description
Current iron supplements on the market are commonly associated with side effects including gastrointestinal distress, nausea, vomiting, and constipation. As a solution, we have developed a novel delivery system for iron supplementation that overcomes many of these limitations. The goal of this study is to assess the efficacy of a yeast-iron complex in improving iron status, gut microbiome, and exercise performance in young, endurance-trained females with sub-optimal iron status. Participants will consume 40mg of elemental iron every second day for 8 weeks. Before and after supplementation,participants will be assessed for exercise capacity (VO2max), iron status, and the current state of the gut microbiome. each week during supplementation, participants will complete a survey in in which they will report feelings of stress and recovery as well as gastrointestinal symptoms.
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- Female
- Target Recruitment
- 30
- cis-gendered female 18-25years old
- sub-optimal iron status (ferritin ≤45mcg/ L)
- At least 1 year past the age of menarche
- Engage in moderate to vigorous endurance activity for at least 3 hours a week
- Supplemented with iron iron (>5mg/day), prebiotics, or probiotics in last 3 months
- antibiotic use in last 3 months
-
- Energy availability >30 kcal/kg lean body mass
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Iron/yeast complex (FeSC) FeSC Iron Supplement
- Primary Outcome Measures
Name Time Method Iron Status 4 weeks, 8 weeks Ferritin
Hemoglobin 4 weeks, 8 weeks Hemoglobin concentration
Upper Gut Microbiome 4 weeks, 8 weeks SIMBA capsule
Lower Gut microbiome 4 weeks, 8 weeks Fecal sample
- Secondary Outcome Measures
Name Time Method Hemoglobin Mass 8 weeks Carbon monoxide Rebreathing Technique
Exercise Capacity 8 weeks Oxygen Consumption (VO2max)
Gastrointestinal Symptoms 1 Weekly for 8 weeks Gastrointestinal Symptoms Questionnaire